Case study 3 – A diabetic patient with COVID-19
All oral antidiabetic therapies should be discontinued in diabetic patients with severe COVID-19 infection requiring ICU admission.
To access this module, please register or login:
ATTENTION! Kindly note that if you were in attendance of the live webinar you have already received 1 CPD point and will not be permitted to receive additional points for the report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report.